In plants, viral synergisms occur when one virus enhances infection by a distinct or unrelated virus. Such synergisms may be unidirectional or mutualistic but, in either case, synergism implies that protein(s) from one virus can enhance infection by another. A mechanistically related phenomenon is transcomplementation, in which a viral protein, usually expressed from a transgene, enhances or supports the infection of a virus from a distinct species. To gain an insight into the characteristics and limitations of these helper functions of individual viral genes, and to assess their effects on the plant-pathogen relationship, reports of successful synergism and transcomplementation were compiled from the peer-reviewed literature and combined with data from successful viral gene exchange experiments. Results from these experiments were tabulated to highlight the phylogenetic relationship between the helper and dependent viruses and, where possible, to identify the protein responsible for the altered infection process. The analysis of more than 150 publications, each containing one or more reports of successful exchanges, transcomplementation or synergism, revealed the following: (i) diverse viral traits can be enhanced by synergism and transcomplementation; these include the expansion of host range, acquisition of mechanical transmission, enhanced specific infectivity, enhanced cell-to-cell and long-distance movement, elevated or novel vector transmission, elevated viral titre and enhanced seed transmission; (ii) transcomplementation and synergism are mediated by many viral proteins, including inhibitors of gene silencing, replicases, coat proteins and movement proteins; (iii) although more frequent between closely related viruses, transcomplementation and synergism can occur between viruses that are phylogenetically highly divergent. As indicators of the interoperability of viral genes, these results are of general interest, but they can also be applied to the risk assessment of transgenic crops expressing viral proteins. In particular, they can contribute to the identification of potential hazards, and can be used to identify data gaps and limitations in predicting the likelihood of transgene-mediated transcomplementation.
S U M M A RY
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I N T R O D U C T I O N
A synergism may be said to occur when, during the simultaneous infection of a plant by two distinct viruses, infection of one or both viruses is enhanced (Atabekov and Taliansky, 1990; Close, 1964; Falk et al. , 1995; Froissart et al. , 2002; Malyshenko et al. , 1989; Smith, 1945) . When synergisms are asymmetric, the two viruses are often referred to as the 'helper' and the 'dependent' viruses (Malyshenko et al. , 1989) . Viral synergisms are assumed, in this paper and elsewhere, to be protein-mediated and, in some cases, this assumption is supported, as the synergism can be mimicked in transgenic plants expressing single viral proteins (Giesman-Cookmeyer et al. , 1995; Vance, 1991; Vance et al. , 1995) .
Transcomplementation (sometimes called heterologous complementation) is a related phenomenon, in which a viral protein, often expressed from an integrated transgene, supports or enhances infection by an invading 'dependent' virus. A wellknown example of this is the enhancement of diverse plant viruses in tobacco by transgenes encompassing the HC-Pro region of potato virus Y (PVY) (e.g. Pruss et al ., 1997; Vance et al ., 1995) .
Two additional experimental techniques can also demonstrate transcomplementation. The first includes experiments in which individual viral genes are successfully exchanged or replaced to produce functional hybrid viruses (e.g. Briddon et al. , 1990; Huppert et al. , 2002; de Jong and Ahlquist, 1992) . The second includes transient assays in which a viral gene and a putative dependent virus are introduced simultaneously by cobombardment (Agranovsky et al. , 1998; Morozov et al. , 1997) . The purpose of this review is to update and extend our conceptual understanding of the extent to which infecting viruses may utilize proteins derived from distinct viruses. The data reviewed here are organized, in particular, to help to determine whether the expression of viral proteins in transgenic plants is likely to result in altered infection by non-target viruses.
M O L E C U L A R P L A N T P A T H O L O G Y (
This review is also the first to specifically and systematically address the principal questions relevant to the risk assessment of transcomplementation arising from viral protein expression in transgenic plants (although for coat proteins, see Falk et al. , 1995; de Zoeten, 1991) . These questions are as follows: (i) how common are synergism and transcomplementation between plant viruses that are phylogenetically distinct (at the species level or above, see 
A N OV E RV I E W O F S Y N E R G I S M S A N D T R A N S C O M P L E M E N TAT I O N
Synergisms and examples of transcomplementation discussed in this review are restricted to those in which there is a clear and measurable positive effect on the dependent virus (e.g. enhanced viral titre or a newly acquired ability to infect a non-host plant); they are documented in Table 1 . The examples included in Table 1 are also restricted in requiring that the dependent virus comes from a distinct species. Thus, synergisms which result only in an enhancement of symptoms or which occur between viruses of the same species are not discussed here or included in Table 1 . Also not discussed here are transcapsidation results obtained in vitro , and these are reviewed elsewhere (Dodds and Hamilton, 1976) . In addition, although plant viruses have close associations with viroids, and viroids can utilize viruses for transmission and possibly other functions, we do not discuss the potential for transcomplementation to alter the infection of plants by viroids (Syller and Marczewski, 2001) . Table 1 documents the instances of synergism or transcomplementation reported in the scientific literature. These are displayed to highlight the phylogenetic relationship between the helper and dependent viruses involved. Where possible, the 'helper' protein is identified.
The findings summarized in Table 1 allow a broad set of generalizations to be made about synergisms and transcomplementation. Firstly, they are very common: 69 virus species from 35 genera have been shown to function as either a helper or a dependent virus, and most well-studied viruses appear in Table 1 on multiple occasions. As an example, the tobacco mosaic virus (TMV) can function as a helper to 17 viral species in 16 different genera, and, as a dependent virus, TMV appears 20 times with dependence on 16 different genera (Table 1) . Such promiscuity suggests that many of the empty boxes in Table 1 reflect data gaps rather than an underlying biological incompatibility. Nevertheless, synergism or transcomplementation is not universally observed, and there are many recorded instances of negative results (e.g. Hamilton and Nichols, 1977; Rao et al. , 1998) , and also sometimes of interference between viruses (e.g. Mendez-Lozano et al. , 2003) .
A second generalization is that synergisms and transcomplementation can occur between highly divergent viruses. Table 1 documents synergisms of both single-stranded and doublestranded DNA viruses with RNA viruses (e.g. Carr and Kim, 1983; Cooper et al. , 1995; Wege and Siegmund, 2007) , of both ambisense and negative-stranded RNA viruses with positive-stranded RNA viruses (Huang et al ., 2005; Lewandowski and Adkins, 2005) , and between viruses with diverse life histories, morphological structures and genome characteristics, perhaps the most notable of the latter being the extension of the host range of the insect virus flock house virus (FHV) to plants (Dasgupta et al ., 2001) . Nevertheless, there are no instances in which ambisense viruses or negative sense RNA viruses are the dependent virus (Table 1) . It is not known whether this lack of evidence reflects the relative lack of research on these viruses or an innate incompatibility.
A third generalization is that a very diverse set of viral proteins, including some of unknown function, can transcomplement (Hormuzdi and Bisaro, 1995; Teycheney et al ., 2000) . Nevertheless, transcomplementation has most commonly been shown for viral proteins that are classed as movement proteins, inhibitors of gene silencing or coat proteins (see Table 1 ).
All the findings above are apparent from a study of Table 1 . However, a more detailed examination of the papers referred to in Table 1 reveals additional important characteristics of transcomplementation and synergism. Firstly, plant viral life cycles are highly complex and require the fulfilment of diverse functions by a limited set of often multifunctional viral proteins. Given this context, it is perhaps not surprising that the infection characteristics enhanced by transcomplementation and synergism are diverse. Synergisms or transcomplementation can confer, enhance or compensate for a lack of viral functions as different as mechanical transmission (Mayo et al. , 2000; Ryabov et al. , 2001) , host range (e.g. Cohen et al. , 1988; Dasgupta et al. , 2001; Hacker and Fowler, 2000; Hamilton and Nichols, 1977; Spitsin et al. , 1999) , seed transmission (Kuhn and Dawson, 1973) , specific infectivity (Chiba et al. , 2006; Sunter et al. , 2001) , cell-to-cell and long-distance movement (e.g. Carr and Kim, 1983; Yelina et al. , 2002) , vector transmission (e.g. Briddon et al. , 1990; Lecoq et al. , 1993; Rochow, 1970) , viral titre (e.g. Scheets, 1998; Valkonen, 1992) , disease development (Cooper et al. , 1995) and genome activation (e.g. (Creamer and Falk, 1990; Rochow, 1970; Wen and Lister, 1991) Luteovirus (Gill and Chong, 1981) Umbravirus (Hull and Adams, 1968; Okusanya and Watson, 1966; Smith, 1945 Smith, , 1946 Waterhouse and Murant, 1983; Watson et al ., 1964) Polerovirus Potexvirus (Pfeffer et al ., 2002) Umbravirus (Falk et al ., 1979; Waterhouse and Murant, 1983) Potyvirus (Wintermantel, 2005) Closterovirus (Wintermantel, 2005) Enamovirus Polerovirus (Mayo et al ., 2000) Tombusvirus (Savenkov and Valkonen, 2001b ) Hordeivirus (Yelina et al., 2002) Potyvirus (Lecoq and Pitrat, 1985; Pirone, 1981; Sako and Ogata, 1981) Tobamovirus (Malyshenko et al., 1989 ) Luteovirus (Bourdin and Lecoq, 1994 ) Polerovirus (Barker, 1987 (Barker, , 1989 Jayasinghe et al., 1989; Wintermantel, 2005 ) Machlomovirus (Goldberg and Brakke, 1987) Comovirus (Anjos et al., 1992; Calvert and Ghabrial, 1983) Potexvirus (Fedorkin et al., 2000 (Fedorkin et al., , 2001 Helper virus* (Ryabov et al., 1998) Tobamovirus (Ryabov et al., 2001b) Enamovirus (Mayo et al., 2000) Polerovirus (Barker, 1989; Mayo et al., 2000) Polerovirus (Ryabov et al., 2001a ) Tobamovirus (Ryabov et al., 1999a ) Cucumovirus (Ryabov et al., 1999b) Bromovirus Bromovirus (Mise et al., 1993) Tobamovirus (Choi and Rao, 2000)
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Secondly, individual proteins may transcomplement multiple viruses. For instance, the red clover necrotic mottle virus (RCNMV) movement protein transcomplements viruses from seven distinct genera, the coat protein of alfalfa mosaic virus (AlMV) can transcomplement viruses from four distinct genera, and the movement protein of TMV can transcomplement members of 13 distinct genera (Table 1) . Perhaps more unexpectedly, when single proteins transcomplement more than one virus, they may, even in a single host species, confer distinct attributes on each virus. Thus, TMV movement protein expressed from a transgene confers elevated titre on a caulimovirus and a nepovirus, accelerates disease development of cucumber mosaic virus (CMV) (without enhancing viral titre) and extends the host range of FHV (Cooper et al., 1995; Dasgupta et al., 2001) . Whether these distinct manifestations of synergism stem from one single attribute of the helper protein, or reflect distinct protein functions, is not yet clear.
Lastly, to function in a synergism, the helper protein or virus must normally be host-adapted. However, there are exceptions to this rule, particularly amongst proteins that inactivate plant defences based on gene silencing (Voinnet et al., 1999) .
Taken as a whole, the data in Table 1 suggest that the ability to discriminate between viruses is not a dominant feature of viral protein function. Nevertheless, there is variation in the extent to which distinct classes of proteins seem able to discriminate, and these differences presumably reflect the mode of action of these proteins. Thus, proteins whose functions are known to require the recognition of specific viral genomic sequences or structures (e.g. coat proteins and replicases) are less likely to show transcomplementation of phylogenetically diverse viruses than proteins whose mode of action does not. However, in the case of replicase proteins, this rule has not been tested to any great extent, and for both coat proteins and replicases there are suggestions that these proteins can be multifunctional and may transcomplement using these 'secondary' functions. For example, some replicases appear to suppress host defences, and coat proteins can expand host range, inhibit gene silencing or show movement functions that may not require the recognition of viral sequences (Abbink et al., 2002; Callaway et al., 2001 Callaway et al., , 2004 Qu et al., 2003; Spitsin et al., 1999; Thomas et al., 2003) .
The above discussion summarizes some of the salient points that can be concluded from the evidence presently available. Nevertheless, in many respects, our understanding is based on a highly limited data set. For instance, synergisms may have diverse consequences, such as effects on infectivity (Chiba et al., 2006; Sunter et al., 2001) , the speed with which infection proceeds (Cooper et al., 1995) , the efficiency of vector acquisition (Aritua et al., 1998) or consequences for seed transmission (Kuhn and Dawson, 1973) , all of which are biologically very important. However, most investigations (especially of transcomplementation) report data on only a small subset of these potential consequences (for example, estimating changes in viral titre). Only relatively rarely do the subset of infection characteristics measured have unambiguous biological significance that would be useful for risk assessments. For instance, transcomplementation by viral suppressors of silencing is often reported to increase viral titre, but this may or may not have epidemiological importance. However, an impact of silencing suppressors that might be predicted and would almost certainly have epidemiological significance is the enhancement of specific infectivity; however, only two papers have reported testing a suppressor for this possibility and, in both cases, enhancement was observed (Chiba et al., 2006; Sunter et al., 2001) . Our hope, therefore, is that one outcome of this review will be that, in future, reports of transcomplementation will provide data on a wider spectrum of infection characteristics, especially those with relevance to risk assessment. If this were to occur, it may well transpire that, as is the case with synergisms, the effects of transcomplementation, even by single proteins, will be found to be more complex and more diverse than the data at present imply.
V I R A L P R OT E I N P R O D U C T I O N I N V I R U S -R E S I S TA N T P L A N T S
As the relevance of transcomplementation and synergism to risk assessment is dependent on the extent to which transgenic virusresistant plants express functional viral proteins, this section examines the evidence for protein expression and transcomplementation in transgenic virus-resistant plants, including those that have so far been approved for commercial release.
Transgenic crop plants coding for full-length proteins of viral origin represent a small but significant proportion of all genetically engineered crops approved worldwide. Listed in Table 2 , they include NewLeaf ® Y potato (potyvirus coat protein), SunUp Papaya (potyvirus coat protein), Newleaf Plus ® potato (polerovirus replicase) and CZW-3 ® squash (two potyvirus coat proteins and a cucumovirus coat protein). All of these transgenic cultivars, as well as two pending US applications, one for a transgenic plum resistant to plum pox virus and one for a papaya ringspotresistant papaya, are usually considered to resist viral infection by the mechanism of homology-dependent gene silencing, although this has not been formally proven (Beachy, 1997) . Similar resistant cultivars containing diverse viral transgenes from a wide range of viruses have been approved for precommercial trials, primarily in the USA (www.nbiap.vt.edu/cfdocs/ fieldtests1.cfm), and others are under development in various countries.
From the perspective of this review, the important question is whether the cultivars described in Table 2 are able to support
transcomplementation. Unfortunately, this question cannot be answered directly, because on only one occasion has any direct test for transcomplementation been performed as part of a formal risk assessment. In this experiment, four plants of CZW-3 squash were infected with papaya ringspot virus (PRV-Fl) (USDA docket 96-002-1). Levels of PRV-Fl were measured and found to be unaltered. No other viruses were tested and, apart from virus concentration, no other infection characteristic was assessed. However, it is known that all transgenic virus-resistant cultivars commercialized so far produce detectable quantities of either full-length viral mRNAs or full-length viral proteins (Table 2 ). In all cases in which protein was found (all were coat proteins), these levels were lower than in (non-transgenic) virus-infected plants.
The detection of full-length proteins and mRNAs in commercialized plants has, nevertheless, not been sufficient to convince regulators in the US that transcomplementation is a possibility (e.g. USDA 97-204-01p; see Table 2 ). They, and others (e.g. Goldbach et al., 2003) , have tended to assume that gene silencing prevents sufficient (or, depending on the authors, any) protein expression, and thus transcomplementation, in virus-resistant plants. The limited evidence available, however, suggests that this conclusion may be premature. Although gene silencing does reduce protein levels, silenced transgenes can constitutively produce protein (Longstaff et al., 1993) . More importantly, transgenes that have been shown to be silenced in the absence of viral infection can nevertheless transcomplement when challenged by non-target viruses (Farinelli et al., 1992; Hammond and Dienelt, 1997; Mlotshwa et al., 2002) .
These observations of transcomplementation by apparently silenced transgenes may be accounted for by two alternative mechanisms. The first possibility is that a minority of transcripts evade silencing, and these transcripts produce sufficient quantities of viral protein to allow transcomplementation. A second possibility is that infecting non-target viruses inhibit gene silencing and thus permit transcomplementation. Support for this second possibility is provided by three lines of evidence: many plant viruses can inhibit gene silencing (e.g. Anandalakshmi et al., 1998; Beclin et al., 1998; Mitter et al., 2003; Pfeffer et al., 2002; Qu et al., 2003; Voinnet et al., 1999) ; infection by non-target viruses can relieve silencing-based resistance directed against target viruses (e.g. Mitter et al., 2003; Savenkov and Valkonen, 2001a) ; and non-target viruses can rapidly induce protein expression from silenced transgenes, and this induction is the basis of an assay used to identify viral proteins that inhibit gene silencing (e.g. Voinnet et al., 1999) .
Experiments that might distinguish between these two alternative mechanisms have yet to be performed, but what seems to be clear is that the justifications noted above for discounting transcomplementation in transgenic virus-resistant plants are contradicted by the available evidence. Instead, non-target viruses infecting a commercial virus-resistant plant, either as Various authors have previously expressed concern that virusresistant transgenic plants that carry viral transgenes may transcomplement non-target viruses. Some have expressed this concern for plant viral proteins in general (Power, 2002) , and others for specific classes of viral proteins, including viral replicases ), movement proteins (Beachy, 1995 , coat proteins (Falk et al., 1995; Hull, 1994; Tepfer, 2002; de Zoeten 1991) and viral inhibitors of plant defences (Hammond et al., 1999; Tepfer, 2002) . Other authors, citing the possibility of transcomplementation, have created experimental resistant lines that cannot produce proteins (e.g. Higgins et al., 2004; Masmoudi et al., 2002) . Nevertheless, developers of commercial transgenic virusresistant cultivars and those responsible for crop approvals have consistently downplayed the biosafety risk arising from transcomplementation (e.g. USDA 97-204-01p), and continue to approve cultivars encoding full-length viral open reading frames (ORFs) for commercial use. Indeed, the US Environmental Protection Agency is currently proposing the extension of this policy to automatically deregulate (i.e. approve) any crop plant containing transgenic coat protein genes derived from plant viruses found in the USA (Federal Register Vol. 72, No. 74, 18 April 2007) .
T R A N S C O M P L E M E N TAT I O N A S A H A Z A R D
In any risk assessment, it is necessary to hypothesize direct or indirect negative outcomes (hazards) whose probability of occurring is then estimated. In the case of transcomplementation occurring in field-grown crops, four clear hazards can be identified. 1 Failure of the transgenic crop is perhaps the most clearcut hazard. Crop failure as a result of transcomplementation may follow from either enhanced infection by an established viral pathogen (e.g. Barker, 1989; Guerini and Murphy, 1999; Jayasinghe et al., 1989; Valkonen, 1992; Wang et al., 2004) or infection by a novel virus, i.e. one that is normally non-infectious (e.g. Cohen et al., 1988; Hacker and Fowler, 2000; Hamilton and Dodds, 1970; Malyshenko et al., 1989; Sonoda et al., 2000) . Such an effect may result not only when a transgene disables host resistance or when it enhances viral spread within or between individual plants, but also when transcomplementation elevates virus titre, accelerates disease development or enhances symptoms. 2 Transcomplementation may lead to the enhanced infection of nearby crops or wild species by non-target viruses (Fuchs et al., 2000; Lecoq et al., 1993) . A number of the outcomes of transcomplementation documented here have the potential for consequences that are observable partially or even only in neighbouring (i.e. non-transgenic) plants, either of the same or distinct species. This hazard can be divided into several components, including: (i) transcomplementation may qualitatively expand opportunities for plant-to-plant transmission (by extending the range of vector species or subspecies that are able to transmit the non-target virus); (ii) transcomplementation may lead to quantitatively enhanced acquisition and transmission of a non-target virus by the vectors that normally transmit that virus; for example, the acquisition of a non-target virus from the transgenic crop may be enhanced by increased susceptibility of the transgenic crop to viral infection, by elevated viral titre, increased speed of infection or expanded tissue distribution within the transgenic crop; (iii) transcomplementation may lead to infection of the transgenic crop by viruses that are new to the crop (e.g. resulting from a loss of resistance), and this may, in turn, affect neighbouring crops (see examples below). It is worth noting that the effects outlined above are, in principle at least, independent of any direct effect on the transgenic crop itself. Thus, they can occur in the absence of any visible effect on the transgenic crop itself (Fuchs et al., 2000; Lecoq et al., 1993) .
Such indirect effects, in which the crop functions essentially as a new or enhanced viral reservoir, are well known to have epidemiological importance (Hooks and Fereres, 2006; Malmstrom et al., 2005) . They can be illustrated by two hypothetical examples that are discussed briefly below. The purpose of these examples, which focus on the event of a crop becoming susceptible to a new viral species, is to show that the necessary preconditions for this hazard can be commonly found in agriculture.
In the USA, soybean commonly hosts Myzus persicae (an insect vector of PVY), but soybean is not itself a host for PVY (Schultz et al., 1985) . If transgenic soybean were to become able to support infection by PVY (as a result of transcomplementation), it would become a reservoir (rather than a sink) for PVY, allowing PVY to become more prevalent on its usual solanaceous host plants. Such hazards would not necessarily be restricted to the immediate geographical area of the susceptible crop, as many insect vectors migrate over large distances and (unlike M. persicae for PVY) retain infectivity for long periods. As a second example, cucurbit yellow stunting disorder (CYSDV) is caused by a cucurbit-infecting closterovirus transmitted semipersistently by the whitefly Bemisia tabaci (Celix et al., 1996) . Whiteflies feed on tomatoes, but tomatoes are resistant to CYSDV. Should their resistance to CYSDV be abolished, CYSDV would probably become more prevalent on cucurbits. 3 A usual response of farmers to virus infection is to deploy insecticides against their insect vectors (Lapidot and Friedmann, 2002) . Increased pesticide use can be predicted if hazards 1 or 2 occur. 4 In supporting transmission by new insects and infection of new plant hosts, transcomplementation may bring together viruses that normally are separated in space or time. If so, transcomplementation may increase opportunities for recombination to generate novel viruses (Roosinck, 1997) .
L I M I TAT I O N S I N P R E D I C T I N G T R A N S C O M P L E M E N TAT I O N
Predicting the likelihood (preferably quantitatively) of carefully defined hazards is necessary to complete the task of risk assessment. Table 1 is intended to serve as a basic guide to reported synergisms and transcomplementation. It provides a starting point for a case-by-case type assessment of any virus-resistant cultivar using data from peer-reviewed publications, and, importantly, it indicates potential data gaps. However, in addition to the gaps, it is possible to identify, from the publications noted in Table 1 , other limitations to the usefulness of the strategy of predictive risk assessment. Some of these limitations are considered below.
One of the most important of these limitations arises from the evidence, from both viral synergism and transcomplementation, that a previously resistant crop plant may become susceptible to a wider than usual range of viruses (Cohen et al., 1988; Dasgupta et al., 2001; Hacker and Fowler, 2000; Hamilton and Nichols, 1977; Malyshenko et al., 1989; Sonoda et al., 2000; Spitsin et al., 1999) . Effective risk assessment for this possibility does not require the testing of all known viruses, but it does require specific testing of all those viruses that are carried by insect vectors that normally visit the crop without causing productive infections (Hooks and Fereres, 2006) . Especially in countries in which local knowledge of virus diseases is poor, the identification of candidate viruses for testing will constitute a considerable challenge and may, in practice, prove impossible, particularly as these will vary regionally and even locally.
A second limitation is that synergisms can be affected by the specific strain of the dependent virus, the host species or cultivar and, probably, the virus strain used to make the transgene (Cooper et al., 1995; Hii et al., 2002; Mendez-Lozano et al., 2003; Rao et al., 1998; Voinnet et al., 1999; Wang et al., 2004) . Thus both positive and, perhaps more importantly, negative results cannot confidently be extrapolated to agricultural situations in which the relevant components are not identical. Similarly, interactions between stacked transgenes may also influence the risk. As an example, the movement of brome mosaic virus (BMV) by the CMV movement protein also requires the presence of the CMV coat protein (Nagano et al., 1999) .
A third limitation is illustrated by risk assessments which have historically made presumptions about the biological function of the virus-derived sequence. One such assumption, that the transgene contains no unidentified functional ORFs, has been shown to be incorrect in the case of NewLeaf ® Plus potatoes. NewLeaf ® Plus potatoes express not only the P1 and P2 ORFs of potato leaf roll virus (PLRV), but also 229 of the 273 amino acids of the overlapping P0 ORF, which was identified as a suppressor of host defences only subsequent to risk assessment and commercial release (Pfeffer et al., 2002) .
A related limitation is incomplete current knowledge of viral protein function, which can be inferred from the fact that new functions of both plant viruses and their proteins are continually being discovered (Abbink et al., 2002; Belliure et al., 2005) . Some of these, such as the recent discovery that the coat protein of turnip crinkle virus also inhibits host defence mechanisms, have potential implications for transcomplementation (Qu et al., 2003; Thomas et al., 2003) . This latter example illustrates the difficulty in assuming that assigned classes of protein (movement, replicase, coat protein, etc.) constrain the consequences of transcomplementation. Coat proteins, for example, as well as being capable of transcapsidation, have also been shown to expand host range (Spitsin et al., 1999) , inhibit gene silencing (Qu et al., 2003; Thomas et al., 2003) and transcomplement defects in movement (Fedorkin et al., 2000; Taliansky and GarciaArenal, 1995) . Replicase proteins can inhibit host defences (Abbink et al., 2002) , and movement proteins can confer mechanical transmission (Ryabov et al., 2001) , expand host range (Dasgupta et al., 2001; Fenczik et al., 1995) and increase virulence (Cooper et al., 1995; Schaffer et al., 1995) . These findings reinforce the theory that viral genes are frequently multifunctional and that commonly applied labels, although useful in other contexts, are nevertheless simplistic descriptors of gene functions and are not appropriate in risk assessment. Thus, in the risk assessment of any particular transgenic plant, each and every endpoint that might be a hazard, or lead to one, needs to be tested for specifically and regardless of the protein transferred.
Additional limitations to risk assessment may also result from the changing and/or diverse effects of cropping systems, geographic location, vector type and abundance, availability of alternative hosts and even temperature, all of which can alter either the results or the implications of synergism (Close, 1964; Falk et al., 1995) .
Lastly, viruses may in time adapt to transgenic hosts. For example, cowpea chlorotic mottle virus (CCMV), whose own movement protein was replaced with that of BMV, was not infectious on cowpeas (Mise et al., 1993) . However, four of 42 inoculations of the hybrid virus generated infectious host-adapted mutants. The authors suggested that the number of mutations required to adapt the hybrid CCMV to the host was small. Thus, transcomplementation modifies the selective environment and, by lowering host barriers to infection, may create opportunities for pathogen evolution.
These confounding factors place severe constraints on the likelihood that published results, or even any conceivable risk assessment process, will accurately predict the hazards noted above for commercial transgenic plants. It will perhaps be argued that plant breeders will detect the negative consequences of transcomplementation and discontinue development of the transgenic cultivar. It is perfectly possible that they may notice susceptibility to novel pathogens, but it should be noted that the difficulties for breeders will not be less than those mentioned above. It should also be recognized that commercial breeders have released both transgenic and conventional cultivars that have subsequently turned out to be unexpectedly susceptible, even to well-known pathogens (Brodie, 2003; Colyer et al., 2000; Tomlinson, 1987) .
C O N C L U S I O N S A N D R E C O M M E N DAT I O N S
This review has established that viral transgenes, even those that are normally silenced, may produce viral proteins and may transcomplement non-target viruses (Farinelli et al., 1992; Hammond and Dienelt, 1997; Mlotshwa et al., 2002) . Transcomplementation, although not inevitably observed, can be caused by genes from many viruses, and typically leads to the enhanced replication and spread of non-target viruses within or between plants, and sometimes causes plants to become susceptible to viruses against which they are normally resistant. Importantly, a single viral transgene may transcomplement multiple virus species.
Viral proteins are therefore often indiscriminate facilitators of viral infection. The exceptions to this rule appear to be coat proteins, which, at least in their role as transcapsidators, show some degree of species specificity, as do replicase proteins in their role as polymerases. One explanation for this variability in discrimination is likely to be that many viral proteins interact directly with the plant to disable host defences, thus allowing any virus present to benefit. Nevertheless, significant questions of specificity remain to be answered. Perhaps the most important of these is the extent to which the proteins of DNA viruses can transcomplement RNA viruses, and vice versa. Transcomplementation of a caulimovirus by the movement protein of TMV is the single example of transcomplementation of a DNA virus by an RNA viral protein that cannot at present be explained by the inhibition of host defences (Cooper et al., 1995) . This intriguing observation, which has not been followed up, may indicate a peculiarity of caulimoviruses or of the TMV movement protein, or may represent a general, but so far unexplored, phenomenon.
A further important conclusion of this review is the difficulty of excluding empirically the possibility that transcomplementation will occur in agricultural situations. One response to the possibility of transcomplementation, and which has been specifically accepted by US regulators, is to rely on market disapproval as a mechanism to withdraw any transcomplementing transgenic cultivars (e.g. USDA 97-204-01p). The effectiveness of this option, however, is open to question. Experience with Starlink ® maize suggests that, even under highly favourable conditions, eradication of a transgene from an agricultural system may take many years (UCS, 2004) . The time taken will vary and will be dependent on ecological variables, such as seed bank survival and the extent of gene flow to other cultivars and wild relatives, as well as social factors, such as speed of discovery and communication, the ability to identify the transgene and levels of seed saving. For many nations and agro-ecosystems, these parameters are unfavourably aligned, and therefore reliance on withdrawal is probably an inappropriate strategy. A second problem is that crop failure, such as might result from the loss of virus resistance, is sometimes not an acceptable outcome. This is particularly true for staple crops anywhere, but especially in regions in which food security and farm incomes are low. A third problem is that it is far from clear whether a virus that takes advantage of transcomplementation will necessarily revert to its original host range. A fourth is that, as described above, the effects of transcomplementation may not be limited to, or even found at all in, the transgenic crop itself.
Viral protein expression appears to be an unnecessary consequence of engineering virus resistance (Higgins et al., 2004; Masmoudi et al., 2002; Niu et al., 2006; Waterhouse et al., 1998) . A straightforward and technically simple solution is therefore to ensure that the transgene contains a series of termination codons or frame shift mutations that prevent or disrupt protein production. This preventative measure has been proposed or specifically recommended by almost all authors of papers reviewing the risks of transgenic virus-resistant plants, and yet it has not been adopted by commercial producers and it is still not required by regulators (Beachy, 1995; Hammond et al., 1999; Miller et al., 1997; Tepfer, 1993 Tepfer, , 2002 . Disruption should be applied to all potential viral ORFs (in case functional proteins have been overlooked). It should also be applied regardless of any presumed protein function, and should be performed using multiple dispersed termination codons, because any single termination codon may be fully or partially ineffective. These precautions are also necessary because even truncated viral proteins may support synergisms (Sunter et al., 2001) . Indeed, there are even reports in which a truncated protein demonstrated a transcomplementation function lacking in the full-length protein (e.g. Nagano et al., 2001) . The final recommendation is that viral sequences should be as short as possible, and that applicants should demonstrate this fact experimentally as a condition of approval. An alternative approach that has also shown promise for conferring virus resistance is the use of transgenes containing inverted repeats of short viral sequences (Waterhouse et al., 1998) . Precautions such as those listed above should nevertheless still be taken to ensure that viral protein expression is avoided.
Disabling protein expression has two significant additional benefits. Firstly, it will greatly reduce any risks from viral/transgene recombination. Secondly, viral proteins are derived from pathogens. Unexpected and undetected negative effects of viral proteins on plant health or even human health might occur, and would be prevented by avoiding protein expression. Taken together, these recommendations are in line with an important but widely underestimated aspect of safe technologies: that safety is established not only by risk assessment but by safeguards incorporated in good design (Kapuscinski et al., 2003) . 
